NVS
Novartis AG
$89.49
Earnings Summary
Revenue | $12716Mn |
Net Profits | $1125Mn |
Net Profit Margins | 8.85% |
Highlights
Novartis AG’s revenue fell -6.94% since last year same period to $12716Mn in the Q4 2019. On a quarterly growth basis, Novartis AG has generated 1.87% jump in its revenue since last 3-months.
Novartis AG’s net profit fell -5.86% since last year same period to $1125Mn in the Q4 2019. On a quarterly growth basis, Novartis AG has generated -44.91% fall in its net profits since last 3-months.
Novartis AG’s net profit margin jumped 1.16% since last year same period to 8.85% in the Q4 2019. On a quarterly growth basis, Novartis AG has generated -45.92% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Novartis AG post its latest quarter earnings
EPS Estimate Current Quarter | 1.57 |
EPS Estimate Current Year | 1.57 |
Highlights
Novartis AG’s earning per share (EPS) estimates for the current quarter stand at 1.57 - a 14.6% jump from last quarter’s estimates.
Novartis AG’s earning per share (EPS) estimates for the current year stand at 1.57.
Key Ratios
Key ratios of the Novartis AG post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Novartis AG’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Novartis AG has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2021-06-30 | 1.53 | 1.66 | 8.5% |
2021-12-31 | 1.41 | 1.4 | -0.71% |
2021-03-31 | 1.59 | 1.52 | -4.4% |
2021-09-30 | 1.65 | 1.71 | 3.64% |
Company Information
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States. It is one of the largest pharmaceutical companies in the world.
Organisation | Novartis AG |
Headquarters | Lichtstrasse 35, Basel, Switzerland, 4056 |
Employees | 108000 |
Industry | Health Technology |
CEO | Vasant Narasimhan |
Discover More Earning Stocks in Health Technology Sector
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*